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Abstract In the past few years, overwhelming evidence
has accrued that a high level of expression of the protein
neuroglobin protects neurons in vitro, in animal models, and
in humans, against cell death associated with hypoxic and
amyloid insult. However, until now, the exact mechanism
of neuroglobin’s protective action has not been determined.
Using cell biology and biochemical approaches we dem-
onstrate that neuroglobin inhibits the intrinsic pathway of
apoptosis in vitro and intervenes in activation of pro-cas-
pase 9 by interaction with cytochrome c. Using systems
level information of the apoptotic signalling reactions we
have developed a quantitative model of neuroglobin inhi-
bition of apoptosis, which simulates neuroglobin blocking
of apoptosome formation at a single cell level. Furthermore,
this model allows us to explore the effect of neuroglobin in
conditions not easily accessible to experimental study. We
found that the protection of neurons by neuroglobin is very
concentration sensitive. The impact of neuroglobin may
arise from both its binding to cytochrome c and its sub-
sequent redox reaction, although the binding alone is
sufficient to block pro-caspase 9 activation. These data
provides an explanation the action of neuroglobin in the
protection of nerve cells from unwanted apoptosis.
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Introduction
Apoptosis, an evolutionarily conserved form of cell death,
is one of the most complex signalling pathways known.
There are two main initiation pathways of apoptosis: the
death receptor (extrinsic) pathway and the mitochondrial
(intrinsic) pathway. The latter can be triggered by cytotoxic
stress that induces the activation of BH3-only and multi-
domain pro-apoptotic Bcl-2 family members. In particular,
certain BH3-only proteins, including tBid, directly activate
multidomain Bcl-2 proteins Bax and Bak [1]. This event is
negatively regulated by anti-apoptotic Bcl-2 proteins, such
as Bcl-2, which can be inhibited by another set of BH3-
only proteins referred to as indirect activators [1]. Acti-
vated Bax/Bak oligomerise and lead to mitochondrial outer
membrane permeabilisation (MOMP), causing the release
of pro-apoptotic intermembrane proteins including cyto-
chrome c. Once in the cytosol, cytochrome c in the pres-
ence of (d)ATP initiates the oligomerisation of Apaf-1
(apoptotic protease activating factor 1) into a large protein
scaffold, the apoptosome, which recruits and processes pro-
caspase 9 into an active initiator caspase 9. The initiator
caspase 9 then activates the executioner caspases, such as
caspase 3, which bring about the apoptotic destruction of
the cell. This process is illustrated in Fig. S1.
Activation of effector caspases is considered as a point
of no return in the apoptotic process. Therefore, the up-
Electronic supplementary material The online version of this
article (doi:10.1007/s10495-009-0436-5) contains supplementary
material, which is available to authorized users.
S. Raychaudhuri (&)
Department of Biomedical Engineering, University of
California, Davis, 2521 Genome and Biomedical Sciences Bld.,
451 Health Sciences Drive, Davis, CA 95616-5294, USA
e-mail: raychaudhuri@ucdavis.edu
J. Skommer (&)  K. Henty  N. Birch  T. Brittain (&)
School of Biological Sciences, University of Auckland, Thomas
Bld., 3a Symonds Street, Auckland 1142, New Zealand
e-mail: J.Skommer@auckland.ac.nz
T. Brittain
e-mail: T.Brittain@auckland.ac.nz
123
Apoptosis
DOI 10.1007/s10495-009-0436-5
stream events such as MOMP and apoptosome formation
need to be tightly regulated to ensure that the threshold for
cell death has been reached and unwanted apoptosis will
not occur [2]. Tight control of apoptosis is particularly
advantageous for postmitotic cells such as neurons which
have limited regenerative potential and need to last for the
life of the organism. It has been previously suggested that
the strict regulation of apoptosis in neurons is mediated by
the inhibitor of apoptosis family of proteins (IAPs) and/or
low expression of Apaf-1 [3]. The protein neuroglobin, first
discovered by Burmester [4] during a bioinformatics search
of the human genome for previously undiscovered heme
proteins, also protects neural cells from a variety of
apoptotic insults. The heme protein neuroglobin is found at
high levels in certain neurons, endocrine cells and retinal
rod cells, where it can reach a local concentration of
100 lM and is closely associated with mitochondria [5].
Over recent years neuroglobin has been shown to provide a
protective function with respect to amyloid toxicity [6] and
Alzheimer’s disease [7], whilst also protecting from cell
death associated with hypoxic ischemia both in vitro and in
vivo [8–11]. All these processes are at least in part asso-
ciated with apoptotic cell death. This indicates that neu-
roglobin may provide until now unidentified means of
apoptosis regulation in neurons [12].
Neuroglobin is an iron containing heme protein, and as
such it can exist in either a ferrous or ferric form and can
also take part in redox reactions with other redox active
proteins, such as cytochrome c. The neuroglobin-cyto-
chrome c complex can undergo a redox reaction, where
ferric cytochrome c is reduced to a non-apoptotic ferrous
form [13], lending argument for the hypothesis that the
protective role provided by neuroglobin could arise from
its intervention in the mitochondrial pathway of apoptosis.
In the current study we use a combination of experi-
mental studies and a computational systems biology
approach to investigate the role of neuroglobin in regula-
tion of the mitochondrial pathway of apoptosis. Neuro-
globin prevents cytochrome c-induced caspase 9 activation,
significantly blocking cell death triggered by a BH3
mimetic HA14-1. Computational analysis provides a
quantitative model of neuroglobin inhibition of apoptosis at
a single cell level, which is supported by our experimental
data.
Materials and methods
Cell culture and reagents
Human neuroblastoma SH-SY5Y cells were grown in
advanced DMEM/F12 (1/1) medium (Invitrogen) supple-
mented with L-glutamine, 1% penicillin/streptomycin and
10% fetal bovine serum (Invitrogen) at 37C in humidified
95% air, 5% CO2. Jurkat T cells were grown in RPMI 1640
medium (Invitrogen) supplemented as above. To induce
cell death, SH-SY5Y cells were treated with a small-mol-
ecule BH3 mimetic HA14-1 (Alexis Biochemicals).
Plasmids, transfections, stable cell lines
Vector expressing human neuroglobin was generated using
a human cDNA clone from Origene (Rockville, MD, USA)
subcloned into the KpnI and XbaI sites of pcDNA3.1 and
the construct verified by direct sequencing. Plasmids were
propagated using DH5a competent cells, according to
standard protocols, and purified using EndoFree Maxi Prep
kits (Qiagen). SH-SY5Y cells (1 9 106) were plated on
10 cm tissue culture dishes and transfected with pcDNA3.1
or NGB_pcDNA3.1 using calcium phosphate transfection,
according to standard protocols. 16 h post-transfection
cells were washed 3 times with serum-free medium, and
cultured in fresh medium for 48 h to allow for transgene
expression. The medium was then replaced with selection
medium containing G418 (400 lg/ml; Invitrogen). Eight
to twelve clones from each transfection were selected
following 4 weeks of selection. Based on screening for
neuroglobin expression using a mouse monoclonal anti-
neuroglobin Ab (13C8) (Abcam, Cambridge, UK) three
stable clonal cell lines were selected for further analysis.
qRT-PCR
Total RNA was isolated from both adherent and floating
cells using TRIzol (Invitrogen), according to manufac-
turer’s instructions. cDNA synthesis was performed using a
High Capacity cDNA Reverse Transcription Kit with
RNase Inhibitor (Applied Biosystems), according to man-
ufacturer’s instructions. Quantitative RT-PCRs were per-
formed using 10 ng (RNA equivalents) of cDNA as a
template. Gene-specific primers and probes, and TaqMan
Gene Expression Master Mix were from Applied Biosys-
tems and amplifications were performed using an ABI
Prism 7900 instrument. Data were normalized to 18S
rRNA expression.
Western blotting
Total cell lysates were prepared using RIPA buffer supple-
mented with protease inhibitor cocktail (Roche). Proteins
were separated using 15% gels and transferred onto PVDF
membrane. The membranes were blocked with 5% non-fat
milk in Tris-Buffered Saline-Tween 20 (TBS-T) for 45 min,
followed by incubation with mouse monoclonal anti-neu-
roglobin antibody 13C8 (Abcam, Cambridge, UK), goat
polyclonal anti-neuroglobin antibody E-16 (SantaCruz), or
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mouse monoclonal anti-tubulin antibody at 1:1,000, 1:100
and 1:9,000 dilution, respectively, using 1% milk in TBS-T.
Low-salt TBS-T was used with monoclonal antibodies.
Next, the membranes were washed 4 times in TBS-T, incu-
bated for 45 min with anti-mouse (BioRad) or anti-goat
(Jackson ImmunoResearch Laboratories, West Grove, PA,
USA) HRP-conjugated secondary Abs, washed again 4 times
in TBS-T, and developed using ECL reagent (GE
Healthcare).
Flow cytometry
To assess cell viability, 1.5 9 105/well cells were plated on
24-well plate, and treated on the next day as indicated
(legend Fig. 1). At the end of the experiment, both floating
and adherent cells were collected, washed with PBS,
stained for 5 min with propidium iodide (PI; 1 lg/ml)
(Invitrogen), and analyzed immediately on FACS Calibur
(BD). Cells were also gated based on forward scatter (FSC)
and side scatter (SSC) to exclude cell debris, and next
analyzed based on PI fluorescence using CellQuest (BD).
Colony forming assay
pcDNA3.1 and NGB_pcDNA3.1 stable SH-SY5Y cell
lines were plated at 5 9 104 cells/well in 12-well plates.
The next day the cells were treated with DMSO or HA14-1
(12.5 lM) for 48 h. Cells were then washed, and cultured
in fresh medium. Cells were cultured over 10–12 days in
DMEM/F12 supplemented with 10% FBS, penicillin/
streptomycin, glutamine and G418 (400 lg/ml; Invitro-
gen). Medium was replaced every 3 days. Cell colonies
were stained with Giemsa, fixed in 10% methanol, photo-
graphed, and then counted using ImageJ software.
Bacterial expression and protein purification
Bacterial expression of neuroglobin followed our previ-
ously published protocols [14]. The gene coding for human
neuroglobin was cloned into pET29a. E. coli BL21 (DE3)
was then transformed with the pET plasmid and grown for
2 days at 28C under micro-aerobic conditions without
induction in TB medium supplemented with 10% phos-
phate buffer and kanamycin. Cells were harvested by
centrifugation at 5,000g for 10 min. The cells were next
washed and then ultrasonically lysed in 50 mM Tris buffer
containing 1 mM EDTA and 5 mM DTT at pH 8.0 (lysis
buffer). The cell lysate was centrifuged at 20,000g for
10 min and the supernatant sequentially raised to 30 and
then 60% ammonium sulphate. The final precipitate,
obtained by centrifugation at 20,000g for 20 min, after
being redisolved in 50 mM Tris buffer containing 1 mM
EDTA and 5 mM DTT was then extensively dialysed
against the same buffer. The dialysed solution was chro-
matographed for 120 min on Q Sepharose using XK26
column (Amersham Biosciences) and a linear gradient of
100% lysis buffer and 100% lysis buffer with 200 mM
NaCl. Next, the solution was gel filtered using Superdex 75
column (Amersham Biosciences; 10/300 GL) using lysis
buffer with 150 mM NaCl to elute the sample. Flow rate on
both columns was 1 ml/min. Taking advantage of the
hyper-thermal stability of neuroglobin [15], between col-
umns the neuroglobin containing fraction was heated to
75C for 3 min to remove contaminating proteins. We have
Fig. 1 Over-expression of neuroglobin reduces sensitivity towards
BH3 mimetic-induced cell death. a qRT-PCR (upper panel, n = 3)
and western blot (lower panel) analysis of neuroglobin (Ngb) in stable
SH-SY5Y-derived cell lines. b Flow cytometry analysis reveals that
neuroglobin over-expression partially protects against cell death
induced by 2.5 h exposure to 25 lM HA14-1 (mean ± SD, n = 6).
Results represent the average from 2 control (pcDNA3.1) cell lines
(#2 and #3) and 3 Ngb-over-expressing cell lines (#2, #3, and #4).
c Long-term colony survival of wild-type and neuroglobin-over-
expressing cells following 48 h treatment with 12.5 lM HA14-1
reveals nearly complete protection by neuroglobin (mean ± SD,
n = 10)
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determined the x-ray structure of protein produced by this
method and shown that it is identical to that published for
neuroglobin [16]. The final product purity was assessed by
PAGE and electrospray mass spectral analysis. The form of
neuroglobin employed had Cys-Ser mutations and so
avoided any confounding effects of S–S formation.
Pro-caspase 9 activation
Activation of pro-caspase 9 in the presence of various
forms of neuroglobin was assessed using a caspase 9 assay
recently established in our laboratory. This assay uses the
cytosol obtained from cultured Jurkat cells to provide the
major components of the apoptosome (dATP, Apaf-1 and
pro-caspase 9) [17–19]. Cells, grown as outlined above,
were harvested by centrifugation, washed twice with ice-
cold PBS, and immediately resuspended in four volumes of
ice cold lysis buffer (250 nM sucrose, 10 mM KCl, 20 mM
HEPES, pH 7.4, 1.5 mM MgCl2, 0.5 mM EDTA, 0.5 mM
EGTA, and protease inhibitor mixture (Roche). The
resuspended cells were immediately dounced with a
homogenizer (Thomas PHILA, USA) and Teflon pestle and
the resulting homogenate was centrifuged at 13,200 rpm
for 30 min at 1C. Activation of pro-caspase 9 was initiated
by the addition of ferrous or ferric cytochrome c (6 lM),
either in the absence or presence of added ferric neuro-
globin (6 lM), to the cell lysate. Following an incubation
period of 30 min the activation of pro-caspase 9 was
monitored by following the cleavage of an added lumi-
nescent peptide substrate for caspase 9 (Glo 9, Promega).
The emitted light was measured using a Wallac EnVision
2104 multilabel reader (Perkin Elmer).
Statistical analysis
Differences between the groups were determined by
ANOVA and t-test using SPSS Statistics 17.0.
Computational systems analysis
We use a kinetic Monte Carlo technique to simulate the
signalling reactions in the intrinsic apoptotic pathway.
Details of our simulation method can be found in our
earlier work [20, 21]. Below, we provide a brief outline of
our simulation scheme describing (1) the Monte Carlo
sampling of signaling reactions in the intrinsic apoptotic
pathway, and, (2) how the effect of neuroglobin on the
intrinsic apoptotic pathway is incorporated in our model. In
our Monte Carlo (MC) algorithm, diffusion and reaction
are treated in an equivalent manner by defining probabi-
listic rate constants for both events. Individual molecules
are sampled randomly and two possible moves are con-
sidered—(a) diffusion move, and, (b) reaction move. The
diffusion probability of multi-molecular complexes is
taken to be lower than that of free molecules. For example,
the apoptosome complex, made out of two molecules of
cytochrome c and two molecules of Apaf-1, is considered
immobile. Explicit simulation of individual molecules
allows us to incorporate mutual exclusion of molecules
from occupying the same spatial location. When a mole-
cule is chosen for reaction it can undergo any of the several
reactions possible for that molecular species. Some general
form of reactions are: (1) two free molecules form a
complex with probability Pon, (2) a molecular complex can
dissociate with probability Poff, (3) catalysis reaction such
as proteolitic cleavage of a molecule during dissociation
from a molecular complex (Pcat). Formation of multimo-
lecular complexes such as the apoptosome is handled by
assigning binding pockets with a molecule like cytochrome
c and then defining explicit rules of binding and dissocia-
tion at different binding pockets.
Neuroglobin-cytochrome c reaction
Neuroglobin can bind to cytochrome c (Fig. S1) and pre-
vent apoptosome formation. We assume the following rate
constants for this neuroglobin binding to cytochrome c
reactions: kon = 10
7 M-1 s-1 with an overall affinity
constant KA = 2 9 10
4 M-1 [22].
This simulation is carried out using a three-dimensional
cubic (lattice) box that mimics a cell with signaling mol-
ecules inside it. In our simulations individual molecules are
placed on individual nodes of the simulation box. At the
beginning of the simulation we randomly place all the
molecules either on the cell surface or inside the three-
dimensional simulation box. We have used a previously
developed mapping scheme between probabilistic param-
eters of our model and their physical analogs [20, 21]. Most
of the parameter values, such as kinetic rate constants and
molecular concentrations, used in our simulations are
obtained from [23–27].
Results
Over-expression of neuroglobin protects SH-SY5Y
cells against HA14-1-induced cell death
We have previously hypothesised that the protective role
provided by the presence of neuroglobin could arise from
its intervention in the mitochondrial pathway of apoptosis
[12]. In order to study the anti-apoptotic effects of high
neuroglobin levels we established stable neuroglobin
(Ngb)-overexpressing human neuroblastoma SH-SY5Y
cells (Fig. S2). The overexpression of Ngb was confirmed
using quantitative RT-PCR and western blotting (Fig. 1a).
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The pcDNA3.1 and Ngb-overexpressing cell lines were
treated with DMSO or HA14-1, a BH3 mimetic which
inhibits anti-apoptotic Bcl-2 protein(s) and thus specifically
activates the intrinsic pathway of apoptosis. Using FACS
(fluorescence activated cell sorting) analysis we show that
Ngb-overexpressing cells have an enhanced resistance to
cell death induced by HA14-1. Neuroglobin over-express-
ing cells exposed to HA14-1 (25 lM for 2.5 h) show a
significantly lower rate of cell death than do wild-type cells
during the first hours of treatment (Fig. 1b). Furthermore,
the protective action of neuroglobin was reflected in terms
of long-term survival, as it was found to significantly
increase the clonogenic potential of SH-SY5Y cells fol-
lowing prolonged (12.5 lM for 48 h) exposure to HA14-1
(Fig. 1c). These observations strongly support our
hypothesis that neuroglobin exerts its protective role by
intervening in the mitochondrial pathway of apoptosis.
Computational analysis of the cytochrome
c-neuroglobin complex
We have previously observed that neuroglobin reacts very
rapidly with cytochrome c [12, 13, 22]. Computational
analysis using BiGGER [28] has identified a lowest energy,
putative structure for the cytochrome c-neuroglobin com-
plex formed in this reaction (Fig. 2). The analysis of the
interface amino acids of this structure suggests the binding
of cytochrome c Lys residues 72 and 25 to Glu residues 60
and 87 on neuroglobin. These interactions are likely to be
of functional significance as the Lys residues 72 and 25 of
cytochrome c have previously been identified as mandatory
and important for the binding of cytochrome c to Apaf-1,
respectively [29–32]. Furthermore, their binding partners
on neuroglobin, namely Glu60 and Glu87, are conserved in
the amino acid sequence from frog to human.
Systems level modelling of the intrinsic pathway
of apoptosis indicates that formation of the cytochrome
c-neuroglobin complex suppresses apoptosis
The complex nature of protein signaling networks, such as
apoptotic pathways, with multiple variables acting at the
same time, can be analyzed using a systems level proba-
bilistic approach. Therefore, using systems level informa-
tion of the apoptotic signalling reactions, we have
developed a quantitative model of neuroglobin-mediated
inhibition of apoptosis, which probes the death-protective
role of neuroglobin at a single cell level [21]. This method
is based on a probabilistic Markov chain method in which
the reactivity of all the signalling molecules follows a
stochastic, rather than deterministic behaviour [21]. In our
computational model, the mitochondrial pathway of
apoptosis is initiated by caspase 8-induced activation of a
BH3-only protein, Bid, to tBid. tBid further interacts with a
set of pro- and anti-apoptotic proteins leading to activation
of Bax and its translocation to the mitochondrial surface
(Fig. S1). The activation of Bax in our model is represented
by tBid-Bax and Bax2 complexes, which simulate Bax
oligomerisation induced directly by BH3-only proteins and
by general inhibition of anti-apoptotic Bcl-2 proteins (Fig.
S1). In our computational model, tBid and Bax simulate the
effect of all the BH3-only and multi-domain pro-apoptotic
Bcl-2 proteins, respectively, whereas all the anti-apoptotic
effects are represented by Bcl-2. Mitochondrial cyto-
chrome c is released into the cytosol once Bax activation
reaches a critical threshold determined by a preset number
of Bax2 complexes [33, 34]. The intrinsic stochastic nature
of the signalling reactions up-stream of mitochondria in the
intrinsic pathway of apoptosis makes the Bax2 activation a
stochastic event. The loop network structure of tBid-Bcl-2-
Bax (Fig. S1) and the Bax/Bcl-2 ratio are the critical
determinants of MOMP and cytochrome c release. In our
model cytochrome c is released in an all-or-none manner.
This is in line with recent experimental studies suggesting
that the release of cytochrome c occurs in a rapid (*5 min)
manner once it is initiated, and that this behaviour is cell
type independent [35, 36]. The rapid release of cytochrome
c is initiated by stochastic Bax2 activation and therefore it
is also a stochastic event, with cell-to-cell variation arising
directly from its stochastic nature [21, 27]. Our model
assumes also that cytochrome c, once released into the
cytosol, binds with Apaf-1 and dATP to form the apopto-
some (Fig. S1), with subsequent activation of caspase 9 and
caspase 3 [21]. Finally, we use a lower amount of Bcl-2 in
Fig. 2 Lowest energy soft-docked structure of the complex between
neuroglobin (left) and cytochrome c (right) calculated using BiGGER
[24] and rendered using YASARA (www.yasara.org)
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our simulations to mimic the effect of Bcl-2 inhibitors such
as the BH3-mimetic HA14-1 that was used in our initial
experiments (Fig. S1). Each run of our Monte Carlo sim-
ulation represents activation of apoptosis signalling
through the intrinsic pathway at a single cell level. Inter-
estingly, the time scale of the apoptosis through the
intrinsic pathway emerges naturally from our stochastic
simulations that show slow (*hours) activation, as also
observed in our experimental studies.
In our computational model ferrous neuroglobin binds
with ferric cytochrome c and further changes it to a non-
apoptotic reduced form [13], thus adding to its inhibitory
effect on apoptotic signalling. When a small of amount
of neuroglobin (nM concentrations) is introduced in our
simulations it partially inhibits apoptosome formation by
blocking cytochrome c-Apaf-1 binding. Hence, the acti-
vation of caspase-9 and caspase-3 are also slowed down
with larger cell-to-cell stochastic fluctuations. Increasing
the concentration of neuroglobin exerts a strong effect on
apoptotsome formation and thus apoptosis inhibition. We
analysed the time-course for (1) the first apoptosome
formation, (2) caspase 9 activation, and (3) caspase 3
activation, as we varied the concentration of neuroglobin
(Fig. 3). Clearly, the time-scale of apoptosome formation
(Fig. 3, crosses) correlates well with the subsequent
activation of caspase 9 (Fig. 3, lines) and caspase 3 (Fig.
S2) at a single cell level. The time course of apoptosome
formation is stochastic, with large cell-to-cell variations,
that arise due to three major reasons: (1) release of
cytochrome c into the cytosol is a rapid stochastic event;
(2) the intrinsic kinetic rate constant of cytochrome
c-Apaf-1 complex formation is small; and (3) the
bringing together of multiple pairs of cytochrome c and
Apaf-1 molecules to the same spatial location, by diffu-
sive transport, is a low probability event. Once a few
molecules of apoptosome are formed, activation of cas-
pase-9 and caspase-3 occurs rapidly. Thus, the fluctuation
in the time-course of apoptosome formation is translated
into large fluctuations in caspase-9 and caspase-3 acti-
vation, associated with a sharp spike-like rise of activated
caspases, at a single cell level. Figure 3 shows how
increasing neuroglobin levels lead to slower and lesser
apoptosome formation, in a given simulation time scale;
due to inhibition of the low probability event of apop-
tosome formation. Neuroglobin concentrations in excess
of 1 lM have been reported in mouse brain and retinal
cells [5, 37]. We also calculate the probability distribu-
tion of casapse 3 activation in order to characterize cell-
to-cell stochastic fluctuations in apoptosis signalling
under neuroglobin inhibition. The probability of caspase
3 activation shows a characteristic bi-modal distribution,
over time, that changes due to neuroglobin addition to
the system (Fig. 4; [21]).
Redox reaction between cytochrome c and neuroglobin
is not necessary for the anti-apoptotic action
of neuroglobin, but may modulate it
Previous studies [22] have indicated that ferric neuroglobin
binds to ferric cytochrome c with an equilibrium constant
in the micro-molar range. Our experimental data indicate
Fig. 3 The activation of apoptosome and caspase-9 depend on
neuroglobin concentration. a Neuroglobin = 0, b neuroglo-
bin = 0.01 lM, and c neuroglobin = 0.1 lM. Cytochrome c con-
centration is uniform at 0.1 lM in all three studies. Time is measured
in monte carlo (MC) simulations steps. 1 MC step = 10-4 s, hence
time-scale shown 108 MC steps *2.8 h. Caspase 9 activation is
shown (up to 80% completion) normalized by the maximum. Each
cross and line represent apoptosome formation and caspase 9
activation, respectively, at a single cell level
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that ferric neuroglobin drastically reduces the apoptotic
activity of ferric cytochrome c, whilst itself has no impact
on activation of pro-caspase 9 (Fig. 5a). We also find, in
this reconstituted in vitro system, that caspase 9 activation
by exogenous cytochrome c depends on the redox state of
the added cytochrome c (Fig. 5a). This suggests that the
redox-reaction between cytochrome c and neuroglobin,
even if it is not an absolute requirement, modulates the
neuroglobin-mediated inhibition of cytochrome c-induced
caspase 9 activation. In order to determine the relative
contributions of the binding and redox reactions of neu-
roglobin we have also simulated the alternative mechanism
of apoptosis inhibition by neuroglobin, under the assump-
tion that ferric neuroglobin acts by binding with ferric
cytochrome c but does not reduce the bound cytochrome c.
In such a scenario, the high dissociation constant of the
cytochrome c-neuroglobin complex allows more frequent
association of cytochrome c with Apaf-1, resulting in
Fig. 4 Probability distribution of caspase 3 calculated from single
cell activation data of caspase 3. We show results for two neuroglobin
concentrations: neuroglobin = 0 (white bars) and neuroglo-
bin = 0.01 lM (black bars). Cytochrome c concentration is fixed at
0.1 lM. Caspase 3 concentration (x-axis) is normalized by the
maximum. Time is measured in monte carlo (MC) simulations steps.
1 MC step = 10-4 s
Fig. 5 Neuroglobin binding to cytochrome c is sufficient to block
activation of caspase 9. a Assay of the apoptosome activation of
caspase 9 used the cytosol obtained from cultured Jurkat cells to
provide the major components of the apoptosome (dATP, Apaf-1 and
pro-caspase 9). Apoptosome activation was initiated by the addition
of cytochrome c either in the absence or presence of added
neuroglobin, and the subsequent assembly of the apoptosome
monitored by following the cleavage of a luminescent peptide
substrate for caspase 9. b Caspase 3 activation data without the
neuroglobin reduction of cytochrome c to a non-apoptotic form. We
used cytochrome c 0.1 lM and neuroglobin 0.1 lM in these
simulations. Each line shows the time-course of caspase-3 activation
at the single cell level. Caspase 3 activation is normalized by the
maximum. Time is measured in monte carlo (MC) simulations steps.
1 MC step = 10-4 s
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increased chances of apoptosome formation and thus
increased apoptosis (compare Figs. 3c, 5b). Hence, a
higher level of cytosolic neuroglobin is needed to com-
pletely abolish apoptotic activation in the absence of redox
reaction. However, the qualitative changes due to variation
in neuroglobin concentration, such as slower apoptotic
activation with large cell-to-cell variation, as seen in
Fig. 3, remain unaltered (Fig. 5b).
Increased concentration of cytosolic cytochrome c
requires higher levels of neuroglobin to block apoptosis
We have also modelled the effect of a higher level of
cytochrome c release, upon Bax reaching the preset
threshold activation level. The mitochondria typically
contain sufficient cytochrome c to produce a final con-
centration of approximately 0.5 lM within the cell, if
completely released. Experimental studies, carried out
under controlled conditions, however have shown that 20%
of cytochrome c (*0.1 lM) within mitochondria is free in
the inter-membrane space of the mitochondrion, which can
be released upon mild apoptotic challenge [38] whilst
stronger apoptotic stimuli can result in a higher dose of
cytochrome c release from mitochondria. We used our
computational model to systematically study the effect of
increasing cytochrome c concentration (released into
cytosol) on apoptotic activation. The activation of caspase
3 in our model system is found to be very sensitive to the
ratio of neuroglobin to cytochrome c; increasing [15 fold
when cytosolic cytochrome c concentration is increased
from 0.1 to 0.2 lM, at a fixed 0.1 lM concentration of
neuroglobin (Fig. 6). In these studies we included a cyto-
chrome c-neuroglobin complex dissociation step in our
simulations, in addition to the redox conversion reaction, in
order to better access the amount of neuroglobin needed to
block apoptosis. At a cytochrome c concentration of
*0.2 lM, an equal concentration of neuroglobin was
unable to protect cells from apoptosis, but 0.5 lM neuro-
globin was protective. Thus an increasingly higher level of
neuroglobin is needed to block apoptotic signalling, which
is affected by increases in cytochrome c concentrations in a
non-linear manner. Our modelling data is consistant with
the level of neuroglobin found in nerve cells having the
capacity to protect the cells from mild challenge, such as
those that might arise from calcium fluctuations encoun-
tered during normal nerve function, but permits the initi-
ation of apoptosis on receipt of a stronger apoptotic signal.
Again, this is in line with our experimental data which
shows that the level of neuroglobin expression reached in
our cell culture system (approx. 5 lM) confers better
protection against low-level mitochondrial stress than high-
level stress (Fig. 1b, c and Fig. S3).
Discussion
Neuroglobin is expressed in various regions of the brain
and at particularly high levels in neurons, some endocrine
cell types and in retinal rod cells, reaching up to 100 lM,
in association with mitochondria [5]. Neuroglobin is evo-
lutionarily extremely conserved, with the human and frog
forms being 76% identical in amino acid sequence [5].
Fig. 6 Increased levels of cytochrome c require higher levels of
neuroglobin to block activation of caspase 3. Time course of caspase-
3 activation is shown for three different values of cytochrome c
concentrations: a 0.2 lM, b 0.5 lM, c 1 lM. Neuroglobin concen-
tration is kept fixed at 0.1 lM. Each line shows the time-course of
caspase-3 activation at the single cell level. Caspase 3 activation is
normalized by the maximum. Time is measured in monte carlo (MC)
simulations steps. 1 MC step = 10-4 s. Note the variation in time-
scales in caspase 3 activation as the cytochrome c concentration is
increased
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Significant evidence has been accumulating that this pro-
tein has a physiologically highly significant role. In vivo
and in vitro data have shown that neuroglobin protects cells
from stroke damage, amyloid toxicity and anoxic injury [6,
8–11]. Genetic linkage analysis identified low level of
neuroglobin expression in brain neurons with increased risk
of Alzheimer’s disease [7]. Very recent studies have further
shown that neuroglobin protection of cells undergoing
hyoxia-reperfusion challenge is associated with the main-
tenance of mitochondrial function, ATP concentration and
calcium homeostasis [39, 40].
The exact mechanism by which neuroglobin achieves
this protective activity is still controversial. A number of
potential roles have been suggested for neuroglobin since its
discovery. Initially, the search for a cellular role was
influenced by the mistaken analogy to other heme proteins
such as myoglobin, and thus it was suggested that neuro-
globin could provide a reserve oxygen store. However, it
has since been shown that oxygenated neuroglobin under-
goes rapid autoxidation and has a relatively low binding
affinity for oxygen [37, 41]. Therefore, neuroglobin appears
to have physiological function separate from oxygen stor-
age and transport. A role in nitric oxide (NO) scavenging
was then proposed [42, 43]. Recently, neuroglobin has been
shown to inhibit Rac1-mediated actin assembly and
aggregation of membrane microdomains which are
involved in regulation of death-signal transduction path-
ways [44]. Our hypothesis, that a major physiological role
for neuroglobin is the interception of the mitochondrial
pathway of apoptosis stems from the observation that neu-
roglobin reacts very rapidly with cytochrome c [12, 13, 22].
Moreover, an anti-apoptotic action of neuroglobin at the
immediate post-mitochondrial stage of the intrinsic path-
way of apoptosis may well account for the recently reported
protection of cultured neurons and primary neurons, from
transgenic neuroglobin over-expressing animals, towards
hypoxic challenge [39, 40].
In this work we have combined a system level, Monte
Carlo signalling model of the intrinsic pathway of apop-
tosis with experimental studies to elucidate the functional
mechanism of apoptosis inhibition by neuroglobin. We
observe that neuroglobin over-expressing cells, derived
from a parental neuroblastoma SH-SY5Y cell line, have
significantly increased resistance to cell death induced by a
BH3 mimetic HA14-1, confirming the impact of neuro-
globin on the intrinsic pathway of apoptosis. Initial in vitro
kinetic investigations undertaken in our laboratory identi-
fied a very rapid reaction between reduced (ferrous) neu-
roglobin and oxidised (ferric) cytochrome c which occurs
on the milli-second time scale [13]. A detailed analysis of
the concentration dependence of the neuroglobin-cyto-
chrome c reaction showed that the reaction consists of two
components: (1) initial protein–protein binding and (2)
subsequent electron exchange between the two proteins
[13]. Our systems level computational modelling reveals
that both of these component reactions have the potential to
prevent the activation of the intrinsic apoptotic pathway.
This effect of neuroglobin is associated with the inhibition
of the low probability event of apoptosome formation.
Analysis of caspase 9 activation within the reconstituted
in vitro system reveals that the binding of neuroglobin to
cytochrome c, even in the absence of any redox change, can
significantly decrease activation of pro-caspase 9. Based on
these experimental data we developed a second computa-
tional model to study the anti-apoptotic effects of neuro-
globin, based on the assumption that neuroglobin binds to
ferric cytochrome c but does not reduce it. Under this
assumption a higher concentration of neuroglobin is
required to inhibit apoptosis. Importantly, such a concen-
tration can still be reached in vivo, as shown in our neuro-
globin over-expressing cells, and as reported earlier in
neurons and some endocrine cells. Thus, while redox-reac-
tion between neuroglobin and cytochrome c may increase
the anti-apoptotic activity of neuroglobin, it does not con-
stitute an absolute prerequisite for neuroglobin action.
Mitochondria act as sentinels of diverse stress signals
that emanate from other intracellular organelles, as well as a
variety of environmental stress signals such as low nutrient
levels, increased calcium levels, oxidative stress and intra-
cellular neurofibrillary tangles of abnormally hyperphos-
phorylated tau protein that accumulates in Alzheimer’s
disease. In response to these signals, mitochondria become
ruptured which leads to the release of pro-apoptotic mole-
cules such as cytochrome c and induction of the cascade of
apoptotic events such as formation of the apoptosome and
activation of the initiator caspase 9. It has been shown that
neural cells can survive damage to the mitochondria as long
as the formation of apoptosome is prevented. On the basis of
our combined experimental and computational studies we
propose that neuroglobin inhibits the intrinsic pathway of
apoptosis downstream of mitochondria, where it initially
binds to released cytochrome c and then renders it apop-
totically inactive [13]. The nature of these interactions is
such that they produce a high degree of cell-to-cell sto-
chastic fluctuations in this process. We also hypothesize
that the fundamental role of neuroglobin found in neurons is
to prevent accidental apoptosis occurring due to intracel-
lular stress signals associated with normal cell functioning/
physiology. We propose that the exact concentration of
neuroglobin present in the cell confers a ‘trigger level’ to
the activation of the intrinsic pathway of apoptosis.
Therefore, cells, which during their normal functioning
experience accidental damage to mitochondria, for example
as a result of frequent calcium spikes, may well protect
themselves from cytochrome c-induced caspase activation
by expressing a high level of neuroglobin [45]. The
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identified action of neuroglobin in rendering cytochrome c
apoptotically inactive provides a unique biological platform
on which we can base the design of targeted therapies
against a number of neural diseases.
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
mits any noncommercial use, distribution, and reproduction in any
medium, provided the original author(s) and source are credited.
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